HROW · Harrow Inc. Common Stock
View on chartInsiders & Stakes
| Mark L. Baum Chief Executive Officer | ▲ Buy | Open Market | 2,996,130 Shares held | 5/14/2026 | View profile |
| Andrew R. Boll Chief Financial Officer | ▲ Buy | Open Market | 814,679 Shares held | 5/14/2026 | View profile |
| John P. Saharek President, ImprimisRx | ▼ Sell | Tax Withholding | 467,388 Shares held | 4/7/2025 | View profile |
| Opaleye Management Inc. 10% Owner | ▼ Sell | Open Market | 59,428 Shares held | 3/4/2026 | View profile |
| Makary Martin A. Director | ▲ Buy | Open Market | 45,000 Shares held | 8/14/2023 | View profile |
| Richard L. Lindstrom, MD Director | ▼ Sell | Open Market | 26,100 Shares held | 9/30/2022 | View profile |
| Van Horn R. Lawrence Director | ▲ Buy | Open Market | 1,860 Shares held | 12/22/2022 | View profile |
| Adrienne L. Graves Director | ▲ Buy | Open Market | 1,000 Shares held | 5/18/2026 | View profile |
| Lauren P. Silvernail See Remarks | ▲ Buy | Open Market | 1,000 Shares held | 5/18/2026 | View profile |
| Shojaei Amir CHIEF SCIENTIFIC OFFICER | ▼ Sell | Open Market | 0 Shares held | 8/14/2026 | View profile |
Transaction History
| Shojaei Amir | ▲ Buy | Option Exercise | 11,250 | $405K | 8/14/2026 |
| Shojaei Amir | ▼ Sell | Open Market | 11,250 | $450K | 8/14/2026 |
| Adrienne L. Graves | ▲ Buy | Open Market | 1,000 | $31K | 5/18/2026 |
| Lauren P. Silvernail | ▲ Buy | Open Market | 1,000 | $31K | 5/18/2026 |
| Mark L. Baum | ▲ Buy | Open Market | 10,000 | $302K | 5/14/2026 |
| Andrew R. Boll | ▲ Buy | Open Market | 3,500 | $105K | 5/14/2026 |
| Opaleye Management Inc. | ▼ Sell | Open Market | 134,000 | $5.3M | 3/4/2026 |
| Opaleye Management Inc. | ▼ Sell | Open Market | 4,263 | $169K | 3/4/2026 |
| Opaleye Management Inc. | ▼ Sell | Open Market | 1,309 | $51K | 3/3/2026 |
| Opaleye Management Inc. | ▼ Sell | Open Market | 59,000 | $2.3M | 3/3/2026 |
| Opaleye Management Inc. | ▼ Sell | Open Market | 5,000 | $271K | 2/27/2026 |
| Opaleye Management Inc. | ▼ Sell | Open Market | 20,000 | $1.1M | 1/6/2026 |
| Mark L. Baum | ▲ Buy | Option Exercise | 180,000 | $711K | 12/12/2025 |
| Mark L. Baum | ▼ Sell | Tax Withholding | 79,994 | $3.8M | 12/12/2025 |
| Andrew R. Boll | ▼ Sell | Tax Withholding | 26,665 | $1.3M | 12/12/2025 |
| Andrew R. Boll | ▲ Buy | Option Exercise | 60,000 | $237K | 12/12/2025 |
| Mark L. Baum | ▲ Buy | Option Exercise | 600,000 | $4.7M | 7/21/2025 |
| Mark L. Baum | ▼ Sell | Tax Withholding | 313,338 | $11.6M | 7/21/2025 |
| Opaleye Management Inc. | ▼ Sell | Open Market | 15,000 | $462K | 6/10/2025 |
| Opaleye Management Inc. | ▼ Sell | Open Market | 15,204 | $462K | 6/9/2025 |
| Opaleye Management Inc. | ▼ Sell | Open Market | 1,796 | $54K | 6/4/2025 |
| Opaleye Management Inc. | ▼ Sell | Open Market | 3,000 | $90K | 6/3/2025 |
| Opaleye Management Inc. | ▼ Sell | Open Market | 5,000 | $133K | 5/13/2025 |
| Opaleye Management Inc. | ▼ Sell | Open Market | 10,000 | $259K | 5/12/2025 |
| Andrew R. Boll | ▼ Sell | Tax Withholding | 136,745 | $3.2M | 4/7/2025 |
| John P. Saharek | ▼ Sell | Tax Withholding | 109,475 | $2.5M | 4/7/2025 |
| Mark L. Baum | ▼ Sell | Tax Withholding | 300,363 | $6.9M | 4/7/2025 |
| Andrew R. Boll | ▲ Buy | Option Exercise | 346,500 | $0 | 4/3/2025 |
| John P. Saharek | ▲ Buy | Option Exercise | 277,200 | $0 | 4/3/2025 |
| Mark L. Baum | ▲ Buy | Option Exercise | 762,300 | $0 | 4/3/2025 |
| Opaleye Management Inc. | ▼ Sell | Open Market | 5,000 | $148K | 3/18/2025 |
| Opaleye Management Inc. | ▼ Sell | Open Market | 5,000 | $150K | 3/18/2025 |
| Opaleye Management Inc. | ▼ Sell | Open Market | 5,000 | $140K | 2/28/2025 |
| Opaleye Management Inc. | ▼ Sell | Open Market | 20,000 | $712K | 1/22/2025 |
| John P. Saharek | ▲ Buy | Option Exercise | 90,000 | $663K | 9/11/2024 |
| John P. Saharek | ▼ Sell | Tax Withholding | 45,140 | $1.9M | 9/11/2024 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 20,000 | $199K | 4/25/2024 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 8,285 | $84K | 4/24/2024 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 11,715 | $121K | 4/23/2024 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 29,400 | $310K | 4/19/2024 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 50,000 | $641K | 3/28/2024 |
| Mark L. Baum | ▲ Buy | Open Market | 9,000 | $104K | 3/22/2024 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 50,600 | $488K | 3/20/2024 |
| John P. Saharek | ▲ Buy | Option Exercise | 5,000 | $44K | 3/1/2024 |
| John P. Saharek | ▲ Buy | Option Exercise | 30,000 | $320K | 2/20/2024 |
| John P. Saharek | ▲ Buy | Option Exercise | 12,616 | $135K | 2/20/2024 |
| Andrew R. Boll | ▲ Buy | Option Exercise | 45,000 | $480K | 2/20/2024 |
| Andrew R. Boll | ▲ Buy | Option Exercise | 18,480 | $197K | 2/20/2024 |
| Mark L. Baum | ▲ Buy | Option Exercise | 150,000 | $1.6M | 2/20/2024 |
| Mark L. Baum | ▲ Buy | Option Exercise | 59,836 | $638K | 2/20/2024 |
| Mark L. Baum | ▲ Buy | Option Exercise | 15,400 | $119K | 2/7/2024 |
| Andrew R. Boll | ▲ Buy | Option Exercise | 7,400 | $57K | 2/7/2024 |
| Mark L. Baum | ▲ Buy | Open Market | 7,500 | $61K | 11/16/2023 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 25,000 | $201K | 11/15/2023 |
| John P. Saharek | ▲ Buy | Option Exercise | 20,000 | — | 11/10/2023 |
| John P. Saharek | ▼ Sell | Tax Withholding | 9,778 | $125K | 11/10/2023 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 5,983 | $87K | 9/20/2023 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 14,017 | $205K | 9/19/2023 |
| Mark L. Baum | ▲ Buy | Open Market | 5,800 | $99K | 8/14/2023 |
| Makary Martin A. | ▲ Buy | Open Market | 20,000 | $338K | 8/14/2023 |
| John P. Saharek | ▲ Buy | Option Exercise | 277,200 | — | 7/18/2023 |
| John P. Saharek | ▼ Sell | Tax Withholding | 109,080 | $2.0M | 7/18/2023 |
| Andrew R. Boll | ▲ Buy | Option Exercise | 346,500 | — | 7/18/2023 |
| Andrew R. Boll | ▼ Sell | Tax Withholding | 136,350 | $2.5M | 7/18/2023 |
| Mark L. Baum | ▼ Sell | Tax Withholding | 299,968 | $5.5M | 7/18/2023 |
| Mark L. Baum | ▲ Buy | Option Exercise | 762,300 | — | 7/18/2023 |
| Mark L. Baum | ▲ Buy | Option Exercise | 180,000 | $1.6M | 4/3/2023 |
| Mark L. Baum | ▼ Sell | Tax Withholding | 117,633 | $2.5M | 4/3/2023 |
| Andrew R. Boll | ▲ Buy | Option Exercise | 90,000 | $540K | 3/31/2023 |
| Andrew R. Boll | ▼ Sell | Tax Withholding | 34,442 | $729K | 3/31/2023 |
| Andrew R. Boll | ▼ Sell | Tax Withholding | 9,602 | $142K | 1/2/2023 |
| Mark L. Baum | ▲ Buy | Option Exercise | 88,000 | — | 1/2/2023 |
| Mark L. Baum | ▼ Sell | Tax Withholding | 35,179 | $519K | 1/2/2023 |
| Andrew R. Boll | ▲ Buy | Option Exercise | 23,000 | — | 1/2/2023 |
| Mark L. Baum | ▲ Buy | Open Market | 25,000 | $335K | 12/22/2022 |
| Andrew R. Boll | ▲ Buy | Open Market | 2,500 | $34K | 12/22/2022 |
| Van Horn R. Lawrence | ▲ Buy | Open Market | 1,860 | $25K | 12/22/2022 |
| Makary Martin A. | ▲ Buy | Open Market | 25,000 | $334K | 12/21/2022 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 415,000 | $4.4M | 12/14/2022 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 16,183 | $170K | 12/14/2022 |
| Richard L. Lindstrom, MD | ▼ Sell | Open Market | 40,000 | $505K | 9/30/2022 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 10,000 | $98K | 9/28/2022 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 1,085 | $11K | 9/28/2022 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 10,000 | $68K | 4/13/2022 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 2,832 | $19K | 4/13/2022 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 3,557 | $24K | 4/12/2022 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 25,000 | $169K | 4/12/2022 |
| Andrew R. Boll | ▲ Buy | Option Exercise | 50,000 | — | 2/19/2022 |
| John P. Saharek | ▲ Buy | Option Exercise | 50,000 | — | 2/19/2022 |
| John P. Saharek | ▼ Sell | Tax Withholding | 25,923 | $204K | 2/19/2022 |
| Andrew R. Boll | ▼ Sell | Tax Withholding | 20,605 | $162K | 2/19/2022 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 5,000 | $34K | 1/28/2022 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 1,343 | $9K | 1/28/2022 |
| Mark L. Baum | ▲ Buy | Option Exercise | 125,000 | $300K | 1/20/2022 |
| Mark L. Baum | ▼ Sell | Tax Withholding | 71,406 | $595K | 1/20/2022 |
| Richard L. Lindstrom, MD | ▼ Sell | Open Market | 3,900 | $39K | 9/24/2021 |
| Richard L. Lindstrom, MD | ▼ Sell | Open Market | 5,840 | $53K | 9/16/2021 |
| Richard L. Lindstrom, MD | ▼ Sell | Open Market | 14,160 | $129K | 9/15/2021 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 50,000 | $422K | 8/19/2021 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 2,500 | $21K | 8/19/2021 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 45,000 | $389K | 8/18/2021 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 1,500 | $13K | 8/18/2021 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 25,000 | $214K | 8/17/2021 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 1,000 | $9K | 8/17/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Harrow (HROW) gains analyst support and conference buzz amid turnaround focus
Recent coverage highlights growing attention on Harrow’s ophthalmic pipeline, with analysts maintaining a $63 price target and an average target of $65. A recent conference has generated buzz, while options activity suggests market participants are watching the stock closely. The company’s Q3 results are expected to confirm whether the turnaround plan is taking hold.
Harrow (HROW) gains analyst support and conference buzz amid turnaround focus. Recent coverage highlights growing attention on Harrow’s ophthalmic pipeline, with analysts maintaining a $63 price target and an average target of $65. A recent conference has generated buzz, while options activity suggests market participants are watching the stock closely. The company’s Q3 results are expected to confirm whether the turnaround plan is taking hold.